Navigation Links
2 Independent Studies Released on the Effectiveness of Prostate Cancer Treatment
Date:9/1/2009

WESTMONT, Ill., Sept. 1 /PRNewswire/ -- For years, the debate has been ongoing regarding the best treatment method for prostate cancer patients. Now, two independent studies have reached similar conclusions. Already considered a good option for prostate cancer patients, brachytherapy (radiation seed implants) now has the backing of research from the Prostate Cancer Foundation of Chicago and The Taussig Cancer Center at Cleveland Clinic, proving a superior disease-free survival rate for patients with early stage prostate cancer.

In an 11-year study, the Prostate Cancer Foundation of Chicago, a non-profit organization that funds patient support programs, clinical research and public education, analyzed 9,137 patients between 1997 and 2008 who were treated for prostate cancer with brachytherapy at Chicago Prostate Center. 67.5% of the patients were regarded as low risk, 29.36% as intermediate, and 1.01% as high.

Of those patients, overall cure rates were 96%, 84%, and 75% for low, intermediate, and high risk patients, respectively. When combined with external beam radiation therapy in intermediate and high risk patients, the brachytherapy results far exceed those of surgery.

The Taussig Cancer Center at Cleveland Clinic has released their similar 2008 outcomes, demonstrating brachytherapy to be superior to surgery in all cases. For low risk patients, the study found a 95% survival rate after five years, 89% for intermediate risk, and 71% for high risk patients. This research concluded that, for low risk patients, brachytherapy was equally successful as external beam radiation, but more successful than a radical prostatectomy.

In addition to its effectiveness, brachytherapy is a minimally invasive treatment. Patients with prostate cancer in the T1 or T2 stages (meaning the cancer hasn't spread beyond the prostate) choose brachytherapy for a number of reasons:

  • No incisions, minimal pain and blood loss
  • Urinary incontinence rates less than 1% - compared to 10% with surgery
  • 6-25% chance of sexual dysfunction following procedure - compared to 50% with surgery
  • Lower rates of bowel irritation compared to external beam radiation
  • Convenience - one-time, outpatient procedure, patients can return to normal activity within a day
  • Lower cost compared to external beam radiation and surgery

For more information on the Prostate Cancer Foundation of Chicago research, visit www.chicagoprostatefoundation.org. For more information on the Taussig Cancer Center at Cleveland Clinic, visit http://my.clevelandclinic.org/services/radiation_oncology/outcomes.aspx.


'/>"/>
SOURCE Prostate Cancer Foundation of Chicago
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
2. PCMA Statement on the Independent Drugstore Lobby Agenda
3. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
4. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
5. Nationwide independent Taser study results suggest devices are safe
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. Schwab Institutional Introduces Healthcare and Benefits Assistance for Independent Advisor Firms
8. GHI to Provide Independent Personal Health Advocate for Medicare Members
9. PCMA Statement on Independent Pharmacy Antitrust Legislation
10. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
11. Medical Services Receives Independent Test Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... The Hacking Medicine Institute ... to critically evaluate and rank health-focused applications and connected devices for better disease ... unbiased and accurate information to help accelerate patient and provider adoption of clinically ...
(Date:4/30/2016)... Austin, Texas (PRWEB) , ... April 30, 2016 ... ... time to celebrate the profession and recognize veterinarians’ global impact on public health. ... choose a theme each year, and this year have selected continuing education with ...
(Date:4/30/2016)... Bay, Jamaica (PRWEB) , ... April 30, 2016 ... ... University, and Duane Boise, President and CEO of EMED, today signed a multifaceted ... Jamaica. , EMED and the Northern Caribbean University Department of Natural and Applied ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... 2016 questioned the use of the HyProCure sinus tarsi implant. ( http://www.cbc.ca/news/canada/ottawa/banned-quebec-dentist-pierre-dupont-working-as-chiropodist-in-ottawa-1.3515494 ... EOTTS-HyProCure is a minimally invasive procedure performed, when indicated, to correct the ...
(Date:4/30/2016)... ... ... challenge for all of us, but there are things we can do to improve the odds ... showing more and more that there are simple, yet important steps that can be taken to ... Dr. Kohli’s recommends for her patients include;, , exercise , ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... India , April 29, 2016 ... the life science laboratory due to the growing demands ... by advance technology, contemporary automated systems are already adept ... performed by slow, tedious and manual labor. Instrumentation continues ... were not even conceivable just a few years ago. ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
Breaking Medicine Technology: